US Stock MarketDetailed Quotes

SLDB Solid Biosciences

Watchlist
  • 4.1600
  • +0.1500+3.74%
Close Dec 20 16:00 ET
  • 4.2000
  • +0.0400+0.96%
Post 20:01 ET
166.21MMarket Cap-1.37P/E (TTM)

About Solid Biosciences Company

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Company Profile

SymbolSLDB
Company NameSolid Biosciences
Listing DateJan 26, 2018
Issue Price16.00
Founded2013
CEOMr. Alexander G. Cumbo
MarketNASDAQ
Employees88
Fiscal Year Ends12-31
Address500 Rutherford Avenue,3rd floor
CityCharlestown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-337-4680
Websitehttp://www.solidbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander G. Cumbo
  • President, Chief Executive Officer and Director
  • 918.55K
  • Dr. Paul Herzich, PhD
  • Chief Technology Officer
  • --
  • Kevin Tan
  • Treasurer, Chief Financial Officer and Principal Accounting Officer
  • 1.35M
  • Dr. Jessie Hanrahan, PhD
  • Chief Regulatory Officer
  • --
  • Dr. Jennifer Marlowe, PhD
  • Chief Scientific Officer
  • --
  • David Tyronne Howton
  • Chief Operating Officer, General Counsel and Secretary
  • 648.88K
  • Dr. Gabriel Brooks, M.D.
  • Chief Medical Officer
  • --
  • Ian F. Smith
  • Executive Chairman of the Board
  • 828.65K
  • Ilan Ganot
  • Director
  • 902.09K
  • Dr. Sukumar Nagendran, M.D.
  • Independent Director
  • 106.72K
  • Dr. Clare Kahn, PhD
  • Independent Director
  • 105.72K
  • Lynne Sullivan
  • Independent Director
  • 113.22K
  • Dr. Martin Freed, F.A.C.P.,M.D.
  • Independent Director
  • 114.22K
  • Rajeev Shah
  • Independent Director
  • 104.22K
  • Adam Stone
  • Lead Independent Director
  • 109.72K
  • Dr. Adam M. Koppel, M.D.,PhD
  • Independent Director
  • 94.22K
  • Dr. Georgia Keresty, M.P.H.,PhD
  • Independent Director
  • 101.72K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List